Garde Capital, Inc. Novartis Ag Transaction History
Garde Capital, Inc.
- $1.76 Billion
- Q1 2025
A detailed history of Garde Capital, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Garde Capital, Inc. holds 405 shares of NVS stock, worth $45,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
405Holding current value
$45,850% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.34 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.18 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$974 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$799 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$766 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...